A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer

NCT03306472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Megestrol Acetate 40 MG
DRUG: Megestrol Acetate 160 MG
DRUG: Letrozole

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]